Last reviewed · How we verify

NCT04645576: AF3

Evaluation of the Efficacy and Safety of an Injectable Hyaluronic Acid-based Filler, Art Filler® Volume: Comparative Single-blind Study of the Non-inferiority Versus Juvéderm® Voluma on the Midface, Temple and Jaw-line and Non-comparative Study on the Chin. (AF3)

Completed NA Last updated 8 March 2022
What this trial tests

NA trial testing Face correction with injectable fillers in Aging in 98 participants. Completed in 25 January 2021.

Timeline
14 May 2019
Primary endpoint
2 August 2019
25 January 2021

Quick facts

Lead sponsorLaboratoires FILLMED
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment98
Start date14 May 2019
Primary completion2 August 2019
Estimated completion25 January 2021
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Laboratoires FILLMED

Who can join

19 and older, any sex, with Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The function of injectable fillers for the treatment of dermal contour deformities is to smooth dermal depressions formed by the loss of volume. These fillers (also known as soft tissue augmentation devices) can restore the age-related volume loss of the face, balance the disproportions or correct topographical anomalies. A previous study has already shown the efficacy of Art Filler Volume on the midface, but this study was not comparative. It was thus interesting to compare the efficacy of Art Filler Volume to a reference product but also to test its efficacy on other areas including the temple, jaw-line and chin.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Aging

Currently open trials in the same condition.

Other Laboratoires FILLMED trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04645576.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing